Email ID
Password
Sign me in automatically next time
clinica
Featured
20 April 2014

 
17 April 2014
Improved effectiveness of radiation therapy and enhanced patient safety will be the outcomes of a new standard on radiation therapy (RT) treatments, issued last week by MITA, the US Medical Imaging & Technology Alliance. Specific technical “fail ...
16 April 2014
Johnson & Johnson’s medical devices and diagnostics (MD&D) division was once again a weak spot, with first-quarter sales flat at $7.1bn. Meanwhile, J&J’s Q1 pharmaceutical sales were up 11% year-on-year at $7.5bn, underlining this unit’s increasing ...
15 April 2014
The US market for energy-based ophthalmic surgical systems totalled nearly $1.7bn in 2013 and is expected to experience healthy, mid-single digit growth over the next half-decade. The use of these systems is predicted to increase in refractive ...
14 April 2014
The long-running court battle between Edwards Lifesciences and Medtronic over their transcatheter aortic valve implant (TAVI) devices has taken an unexpected twist: Edwards has been granted a preliminary US injunction against its rival. The ...
 
17 April 2014
Danaher ’s long-time CEO Larry Culp has unexpectedly announced his retirement, overshadowing what Jefferies analyst Brandon Couillard described as a “modest Q1 beat.” Executive vice-president Thomas Joyce will take the reins in what the analyst ...
17 April 2014
As worries mount that the short-lived US IPO window is closing, several firms are scrabbling to take their chance to go public. First up, endovascular graft firm TriVascular Technologies managed to float, but the $78m it raised fell short of its ...
17 April 2014
Improved effectiveness of radiation therapy and enhanced patient safety will be the outcomes of a new standard on radiation therapy (RT) treatments, issued last week by MITA, the US Medical Imaging & Technology Alliance. Specific technical “fail ...
17 April 2014
A recent whitepaper by Citeline demonstrates the growing use of biomarkers in clinical trials, particularly in oncology. This infographic shows how the use of pharmacogenomics biomarkers to select or stratify patients in clinical trials is a ...
 
17 April 2014
Danaher ’s long-time CEO Larry Culp has unexpectedly announced his retirement, overshadowing what Jefferies analyst Brandon Couillard described as a “modest Q1 beat.” Executive vice-president Thomas Joyce will take the reins in what the analyst ...
17 April 2014
As worries mount that the short-lived US IPO window is closing, several firms are scrabbling to take their chance to go public. First up, endovascular graft firm TriVascular Technologies managed to float, but the $78m it raised fell short of its ...
15 April 2014
Lombard Medical Technologies has postponed its plans for an initial public offering in the US, citing poor market conditions. The UK firm, which specialises in endovascular aneurysm repair (EVAR), had previously said it hoped to raise up to $80m, by ...
15 April 2014
Roche’s diagnostics division put in a solid performance during its first fiscal quarter, with its troubled diabetes division “holding up well,” according to Jefferies analyst Jeffrey Holford. Overall, diagnostics sales were up 2% year-on-year as ...
 
17 April 2014
Improved effectiveness of radiation therapy and enhanced patient safety will be the outcomes of a new standard on radiation therapy (RT) treatments, issued last week by MITA, the US Medical Imaging & Technology Alliance. Specific technical “fail ...
16 April 2014
The International Medical Device Regulators Forum is moving closer to finalizing a document on how regulatory authorities recognize or revoke the recognition of auditing organizations that want to take part in the medical device single audit program ...
16 April 2014
The US Food and Drug Administration has issued a further public consultation on the proposed US policy and regulatory framework for health IT applications, including mobile apps. The consultation, announced in a Federal Register notice issued on 7 ...
15 April 2014
The Department of Health in the UK is planning to transfer the oversight of the system of issuing certificates of free sale (CFS) to medical device companies to the national medicines and healthcare products regulator, the MHRA, next year. The move ...
 
Michael Lewis to chair Cambridge Cognition UK neuropsychological testing company Cambridge Cognition has appointed Michael Lewis nonexecutive chair, replacing Dr Jane Worlock, who is stepping ...
Fujifilm Sonosite makes Fujitani CEO Point-of-care ultrasound specialist Fujifilm Sonosite has appointed Naohiro Fujitani president and CEO after previous incumbent Kevin Goodwin stepped ...
Boston Scientific veteran to head up Pixium French retinal implant specialist Pixium has appointed Khalid Ishaque CEO – he joins from medtech giant Boston Scientific, where he has spent 17 ...
09 April 2014
Ashley Yeo

NHS England chief executive Simon Stevens has wasted little time in putting his mark on the service. In office just over a week, he has already decided to work out of London, not Leeds, as predecessor Sir David Nicholson chose to. His first day ...

04 April 2014
Ashley Yeo

Given the strides he made, Zimmer’s David Dvorak will be a hard act to follow as AdvaMed board chairman: implementation of MDUFA III …issuance of final UDI guidance …putting the device tax legislators on the defensive…the AdvaMed strategic ...

 
17 April 2014
Madeleine Armstrong

UK firm Proteome Sciences is hoping to take targeted medicine to a new level. The firm is developing technology to help identify which patients – potentially with any disease – will respond to certain drugs that could be just two years away from the ...

17 April 2014
Amanda Maxwell

Should the EU wait for the introduction of the forthcoming EU IVD Regulation to regulate companion diagnostics or should it create an entirely new and separate regulation for this product group now? And if it does this now, could a new regulatory ...

09 April 2014
Ashley Yeo

NHS England chief executive Simon Stevens has wasted little time in putting his mark on the service. In office just over a week, he has already decided to work out of London, not Leeds, as predecessor Sir David Nicholson chose to. His first day ...

 
17 April 2014
Madeleine Armstrong

UK firm Proteome Sciences is hoping to take targeted medicine to a new level. The firm is developing technology to help identify which patients – potentially with any disease – will respond to certain drugs that could be just two years away from the ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

11 March 2013
Amanda Maxwell

The issue of informed consent for genetic tests dominated discussions at the European Parliament on February 26 during the second half of the meeting, dedicated to the European Commission’s proposed In Vitro Diagnostics Regulations. The tempo of the ...

 
31 May 2012
Hua Gong

Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer ...

 
15 April 2014

Specialty area(s): Protecting brain during transcatheter aortic valve replacement Based in: Santa Rosa, California Founded in: 2009 No. of employees: 25 Total investment received to date: $13m Investors: Private investors

 
24 November 2011
Phil Greenfield

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

 
 
EVENTS
07 May 2014
Linz, AustriaVenue: Design Center LinzEuropaplatz 1, 4020 Linz, Austria http://www.design-center.at/
14 May 2014
Sheraton Brussels Hotel | Brussels | Belgium
14 May 2014
The Hotel. Brussels, Brussels, Belgium
 
© 2014 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36